Search
Search Results
-
Lipoprotein(a): what clinicians need to know
230PDF: 559HTML: 23 -
Modulation of cardiac metabolism in heart failure
2314PDF: 1131HTML: 20 -
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
818PDF: 2302Supplementary: 305Appendix: 251 -
Epidemiology of peripartum cardiomyopathy in Africa
2194PDF: 488HTML: 79 -
-
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
127PDF: 206Supplementary: 142HTML: 17 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
730PDF: 197Supplementary: 140Appendix: 110HTML: 21 -
Applicability of obesity clinical practice guidelines in low- and middle-income countries
986PDF: 513Appendix: 136HTML: 13 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
737PDF: 182Supplementary: 145Appendix: 104HTML: 24 -
Evolving targets for heart failure: the journey so far
1967pdf: 309HTML: 4 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1052pdf: 234Supplementary Material: 38HTML: 103 -
-
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3293PDF: 500Appendix: 375HTML: 24

